The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A standardized workflow to improve the consent process among patients initiating an oral anticancer drug.
 
Jessica S. Brown
No Relationships to Disclose
 
Dawn L. Hershman
Consulting or Advisory Role - AIM Specialty Health
 
Daniel O'Neil
Honoraria - Ipsen
 
Lois Brafman
No Relationships to Disclose
 
Deborah A. Fuentes
No Relationships to Disclose
 
Laura Graafland
Consulting or Advisory Role - Immunomedics
Speakers' Bureau - Immunomedics
Travel, Accommodations, Expenses - Immunomedics
 
Cynthia Law
No Relationships to Disclose
 
Meghna S. Trivedi
Honoraria - Onclive
 
Kevin Kalinsky
Stock and Other Ownership Interests - Array BioPharma (I); Novartis (I)
Consulting or Advisory Role - Amgen; AstraZeneca; bioTheranostics; Eisai; Genentech/Roche; immunomedics; Ipsen; Lilly; Novartis; Odonate Therapeutics; pfizer
Speakers' Bureau - Lilly
Research Funding - Acetylon Pharmaceuticals (Inst); Amgen (Inst); Calithera Biosciences (Inst); CytomX Therapeutics (Inst); Genentech/Roche (Inst); Immunomedics (Inst); incyte (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); Seagen (Inst); Zeno Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Amgen; Genentech; Lilly; Novartis
Other Relationship - Immunomedics
 
Katherine D. Crew
No Relationships to Disclose
 
Melissa Kate Accordino
Honoraria - Charter Oak Research; Deerfield Management; Enterprise Analysis Corporation; ExpertConnect; Incrowd; M3; M3 (I); MDoutlook; Medpanel; Medscape; Medscape; medsurvey; OCN; Sermo; Sermo (I)
Research Funding - TRIO US; TRIO US
Other Relationship - Onclive